Co-delivery of IOX1 and doxorubicin for antibody-independent cancer chemo-immunotherapy
Sign Up to like & getrecommendations! Published in 2021 at "Nature Communications"
DOI: 10.1038/s41467-021-22407-6
Abstract: Anti-programmed cell death-1 (PD-1)/programmed cell death-ligand 1 (PD-L1) antibodies are currently used in the clinic to interupt the PD-1/PD-L1 immune checkpoint, which reverses T cell dysfunction/exhaustion and shows success in treating cancer. Here, we report… read more here.
Keywords: cancer chemo; chemo immunotherapy; antibody independent; iox1 ... See more keywords